Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients
NCT ID: NCT03444259
Last Updated: 2024-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
1001 participants
OBSERVATIONAL
2016-02-01
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiovascular Health Improvement Project
NCT02306200
Cardiology Biobank Registry
NCT00378924
Cancer Survivor Cardiomyopathy Detection
NCT05201014
An Integrative-"Omics" Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China
NCT03076580
Coronary CT Angiography Using 320-Row Volume CT in Patients With Atrial Fibrillation
NCT00968279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Atrial fibrillation
Patients with atrial fibrillation
Cardiac surgery
Open heart surgery
Coronary bypass
Patients undergoing coronary bypass
Cardiac surgery
Open heart surgery
Aortic valve replacement
Patients undergoing aortic valve replacement
Cardiac surgery
Open heart surgery
Mitral valve repair
Patients undergoing mitral valve repair
Cardiac surgery
Open heart surgery
Other
Patients undergoing cardiac surgery for indication other than above
Cardiac surgery
Open heart surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac surgery
Open heart surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent
* All-comers design
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brigham and Women's Hospital
OTHER
University of Turku
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tuomas Kiviniemi
Cardiologist, MD, PhD, FESC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tuomas O Kiviniemi, MD, PhD
Role: STUDY_DIRECTOR
Turku University Hospital
Jarmo Gunn, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Turku University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Turku University Hospital
Turku, , Finland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Maaniitty E, Sinisilta S, Jalkanen J, Vasankari T, Biancari F, Gunn J, Jalkanen S, Airaksinen KEJ, Hollmen M, Kiviniemi T. Distinct circulating cytokine levels in patients with angiography-proven coronary artery disease compared to disease-free controls. Int J Cardiol Cardiovasc Risk Prev. 2024 Jul 4;22:200307. doi: 10.1016/j.ijcrp.2024.200307. eCollection 2024 Sep.
Maaniitty E, Jalkanen J, Sinisilta S, Gunn J, Vasankari T, Biancari F, Jalkanen S, Airaksinen KEJ, Hollmen M, Kiviniemi T. Differential circulating cytokine profiles in acute coronary syndrome versus stable coronary artery disease. Sci Rep. 2024 Jul 27;14(1):17269. doi: 10.1038/s41598-024-68333-7.
Viikinkoski E, Jalkanen J, Gunn J, Vasankari T, Lehto J, Valtonen M, Biancari F, Jalkanen S, Airaksinen KEJ, Hollmen M, Kiviniemi TO. Red blood cell transfusion induces abnormal HIF-1alpha response to cytokine storm after adult cardiac surgery. Sci Rep. 2021 Nov 15;11(1):22230. doi: 10.1038/s41598-021-01695-4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
T273/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.